JP2004520398A5 - - Google Patents

Download PDF

Info

Publication number
JP2004520398A5
JP2004520398A5 JP2002563926A JP2002563926A JP2004520398A5 JP 2004520398 A5 JP2004520398 A5 JP 2004520398A5 JP 2002563926 A JP2002563926 A JP 2002563926A JP 2002563926 A JP2002563926 A JP 2002563926A JP 2004520398 A5 JP2004520398 A5 JP 2004520398A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2002563926A
Other languages
Japanese (ja)
Other versions
JP2004520398A (en
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2002/000497 external-priority patent/WO2002064132A2/en
Publication of JP2004520398A publication Critical patent/JP2004520398A/en
Publication of JP2004520398A5 publication Critical patent/JP2004520398A5/ja
Pending legal-status Critical Current

Links

JP2002563926A 2001-01-18 2002-01-14 Paclitaxel chemotherapy microemulsion composition with improved oral bioavailability Pending JP2004520398A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US26255501P 2001-01-18 2001-01-18
PCT/US2002/000497 WO2002064132A2 (en) 2001-01-18 2002-01-14 Chemotherapeutic microemulsion compositions of paclitaxel with improved oral bioavailability

Publications (2)

Publication Number Publication Date
JP2004520398A JP2004520398A (en) 2004-07-08
JP2004520398A5 true JP2004520398A5 (en) 2005-12-22

Family

ID=22998000

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002563926A Pending JP2004520398A (en) 2001-01-18 2002-01-14 Paclitaxel chemotherapy microemulsion composition with improved oral bioavailability

Country Status (9)

Country Link
EP (1) EP1365759A2 (en)
JP (1) JP2004520398A (en)
AR (1) AR032642A1 (en)
CA (1) CA2434641A1 (en)
MX (1) MXPA03006404A (en)
NZ (1) NZ539046A (en)
PE (1) PE20020833A1 (en)
WO (1) WO2002064132A2 (en)
ZA (1) ZA200305086B (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6750246B1 (en) 2000-02-03 2004-06-15 Bristol-Myers Squibb Company C-4 carbonate taxanes
FR2838349B1 (en) * 2002-04-15 2004-06-25 Laurence Paris LIQUID COMPOSITIONS FOR SUSTAINED RELEASE SOFT CAPSULES AND PROCESS FOR PRODUCING THE SAME
KR100533458B1 (en) 2002-07-20 2005-12-07 대화제약 주식회사 Composition for solubilization of paclitaxel and preparation method thereof
EP1498120A1 (en) * 2003-07-18 2005-01-19 Aventis Pharma S.A. Semi-solid formulations for the oral administration of taxoids
EP1498143A1 (en) * 2003-07-18 2005-01-19 Aventis Pharma S.A. Self-emulsifying and self-microemulsifying formulations for the oral administration of taxoids
US20050123602A1 (en) * 2003-09-25 2005-06-09 Michaelis Arthur F. Rifalazil formulations
CA2611592A1 (en) * 2005-06-17 2006-12-21 Hospira Australia Pty Ltd Liquid pharmaceutical formulations of docetaxel
EP3594248B1 (en) * 2006-10-27 2021-08-04 Capsugel Belgium NV Hydroxypropyl methyl cellulose hard capsules and process of manufacture
US20090088393A1 (en) * 2007-09-28 2009-04-02 Zomanex, Llc Methods and formulations for converting intravenous and injectable drugs into oral dosage forms
KR101053780B1 (en) * 2008-02-29 2011-08-02 동아제약주식회사 Single liquid stable pharmaceutical composition containing docetaxel
JP5868414B2 (en) * 2010-11-08 2016-02-24 カディラ ファーマシューティカルズ リミテッド Taxoid pharmaceutical composition
CN103110581B (en) * 2013-02-26 2015-07-22 西南大学 Taxol microemulsion drug composition and preparation method thereof
KR101542364B1 (en) * 2014-10-31 2015-08-07 대화제약 주식회사 Pharmaceutical composition for oral administration comprising taxanes
ES2895948T3 (en) * 2015-07-30 2022-02-23 Dae Hwa Pharma Co Ltd Pharmaceutical composition for oral administration comprising taxane at high concentration
CN107028931A (en) 2016-02-04 2017-08-11 上海宣泰医药科技有限公司 A kind of taxol drug composition and its pharmaceutical preparation, preparation method and purposes
EP3701943A1 (en) * 2019-02-26 2020-09-02 CAPNOMED GmbH Delayed delivery of anticancer drugs
WO2023220109A1 (en) * 2022-05-11 2023-11-16 Eli Lilly And Company Glp1 pharmaceutical compositions

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998053811A1 (en) * 1997-05-27 1998-12-03 Baker Norton Pharmaceuticals, Inc. Method and compositions for administering taxanes orally to human patients
US6964946B1 (en) * 1995-10-26 2005-11-15 Baker Norton Pharmaceuticals, Inc. Oral pharmaceutical compositions containing taxanes and methods of treatment employing the same
WO1998013359A1 (en) * 1996-09-24 1998-04-02 Marigen S.A. Ultramicroemulsion of spontaneously dispersible concentrates of esters of baccatin-iii compounds with antitumor and antiviral effect
CH688504A5 (en) * 1997-03-26 1997-10-31 Marigen Sa Spontaneously dispersible concentrate containing a taxol analogue
IL133585A0 (en) * 1997-06-20 2001-04-30 Baker Norton Pharma Soluble prodrugs of paclitaxel
IL131217A0 (en) * 1998-03-10 2001-01-28 Napro Biotherapeutics Inc Novel methods and compositions for delivery of taxanes
US6638522B1 (en) * 1998-12-11 2003-10-28 Pharmasolutions, Inc. Microemulsion concentrate composition of cyclosporin
AU768022B2 (en) * 1999-05-27 2003-11-27 Acusphere, Inc. Porous drug matrices and methods of manufacture thereof
US6136846A (en) * 1999-10-25 2000-10-24 Supergen, Inc. Formulation for paclitaxel
US6919370B2 (en) * 2000-11-28 2005-07-19 Transform Pharmaceuticals, Inc. Pharmaceutical formulations comprising paclitaxel, derivatives, and pharmaceutically acceptable salts thereof

Similar Documents

Publication Publication Date Title
BE2019C547I2 (en)
BE2019C510I2 (en)
BE2018C021I2 (en)
BE2017C049I2 (en)
BE2017C005I2 (en)
BE2016C069I2 (en)
BE2016C040I2 (en)
BE2016C013I2 (en)
BE2018C018I2 (en)
BE2016C002I2 (en)
BE2015C078I2 (en)
BE2015C017I2 (en)
BE2014C053I2 (en)
BE2014C051I2 (en)
BE2014C041I2 (en)
BE2014C030I2 (en)
DE60335348D1 (en)
BE2014C016I2 (en)
BE2014C015I2 (en)
BE2013C063I2 (en)
BE2013C039I2 (en)
BRPI0302144B1 (en)
BRPI0215435A2 (en)
BE2013C046I2 (en)
JP2003124903A5 (en)